CMS Opens Way To Add, Or Subtract, Protected Classes In Part D Formularies
Executive Summary
CMS is creating a multi-step process that will give outside experts and the public a role in adding or subtracting "protected" drug classes in Medicare Part D, as well as making exceptions to the rule that all drugs must be covered in a protected class
You may also be interested in...
CMS Defines Terms For Part D Protected Classes, Revises Multi-Step Review
CMS' latest take on policy for "protected classes" under Medicare Part D identifies three key issues that will shape how such classes are chosen in the future: defining terms used in the statutory language, a new approach to the agency's previously proposed multi-step process for evaluating classes, and options for public comment on the agency's choices
CMS Defines Terms For Part D Protected Classes, Revises Multi-Step Review
CMS' latest take on policy for "protected classes" under Medicare Part D identifies three key issues that will shape how such classes are chosen in the future: defining terms used in the statutory language, a new approach to the agency's previously proposed multi-step process for evaluating classes, and options for public comment on the agency's choices
Baucus Reform Framework Not So Taxing On Industry; $23 Bil. Is Fee-Based
Senate Finance Committee Chairman Max Baucus' health care reform legislative framework includes a new proposal to raise revenue from the pharmaceutical industry - a $2.3 billion annual fee based on market share